Åsa Rembratt

Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial

Justo García de Yébenes, G. Bernhard Landwehrmeyer, Ferdinando Squitieri et al. · The Lancet Neurology · 2011 · 172 citations

Medicine, Neurology, Pharmacology +13

Desmopressin treatment in nocturia; an analysis of risk factors for hyponatremia

Åsa Rembratt, A. Riis · Neurourology and Urodynamics · 2005 · 118 citations · Full text

Medicine, Geriatric Medicine, Pharmacotherapy +16

Nocturia and associated morbidity in a community‐dwelling elderly population

Åsa Rembratt, Karin Andersson · British Journal of Urology · 2003 · 73 citations

Medicine, Geriatric Medicine, Urology +17

Pharmacokinetics and pharmacodynamics of desmopressin administered orally versus intravenously at daytime versus night-time in healthy men aged 55?70�years

Åsa Rembratt, Charlotte Graugaard‐Jensen, Thomas Senderovitz et al. · European Journal of Clinical Pharmacology · 2004 · 67 citations

Medicine, Pharmacokinetics, Pharmacology +7

Desmopressin in elderly patients with nocturia: short‐term safety and effects on urine output, sleep and voiding patterns

Åsa Rembratt, K‐E. Andersson · British Journal of Urology · 2003 · 52 citations

Medicine, Pharmacotherapy, Urology +12